Silk Road Medical Inc is a US-based healthcare company with a focus on reducing stroke risk through innovative medical devices. Specializing in transcarotid artery revascularization (TCAR), which combines minimally-invasive techniques with blood flow reversal to protect the brain, Silk Road Medical aims to set a new standard of care. With a medium risk assessment and an ESG score of 27.3, the company's products have shown to decrease morbidity and mortality risks associated with carotid artery disease. Generating revenue solely in the United States, Silk Road Medical is dedicated to sustainability, governance, and environmental impact.